Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115724 · ClinicalTrials.gov registry record · NA
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
A NA study of Cardiovascular Disease, sponsored by Augusta University.
- Active
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT02115724: Active NA study of Cardiovascular Disease, sponsored by Augusta University.
NCT02115724 is a NA study of Cardiovascular Disease that is active but no longer recruiting, run by Augusta University. The registered enrollment target is 74 participants, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02115724, a NA study of Cardiovascular Disease, is active but no longer recruiting, sponsored by Augusta University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
Primary Outcome
Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Antioxidant cocktail
- OTHER Biopsy
- DRUG NMD; 0.4mg sub-lingual nitroglycerin spray
Study Locations (1)
Georgia
- Georgia Prevention Institute , Georgia Regents University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2014-04 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT02115724 still lists
NCT02115724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT02115724 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02115724 about?
NCT02115724 is a clinical study titled "Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)". Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
What is the current status of trial NCT02115724?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2014-04. Estimated completion is 2027-01.
What conditions does trial NCT02115724 study?
This clinical trial studies the following conditions: Cardiovascular Disease.
What interventions are being tested in trial NCT02115724?
The interventions under investigation include: Placebo (OTHER), Antioxidant cocktail (DIETARY_SUPPLEMENT), Biopsy (OTHER), NMD; 0.4mg sub-lingual nitroglycerin spray (DRUG).
Who is sponsoring clinical trial NCT02115724?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02115724 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02115724's enrollment target sits among peer trials
74 88th of 137 higher than 49 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RECRUITING · NA
-
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
RECRUITING · NA
-
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
ACTIVE NOT RECRUITING · NA
-
Home-Based Measures of Physical Activity and Body Composition
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia